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Abstract 
SMAD4 acts as the converging point for TGFβ and BMP signaling in heart development. Here, 
we investigated the role of SMAD4 in heart development using a novel α skeletal muscle actin 
Cre recombinase (MuCre) transgenic mouse strain. Lineage tracing using MuCre/ROSA26LacZ 
reporter mice indicated strong Cre-recombinase expression in developing and adult heart and 
skeletal muscles. In heart development, significant MuCre expression was noted at E11.5 in the 
atrial, ventricular, outflow tract and atrioventricular canal myocardium, but not in the en-
docardial cushions. MuCre-driven conditional deletion of Smad4 in mice caused double outlet 
right ventricle (DORV), ventricular septal defect (VSD), impaired trabeculation and thinning 
of ventricular myocardium, and mid-gestational embryonic lethality. In conclusion, MuCre 
mice effectively delete genes in both heart and skeletal muscles, thus enabling the discovery 
that myocardial Smad4 deletion causes misalignment of the outflow tract and DORV. 
Key words: heart, myogenesis, transforming growth factor beta, SMAD, Marfan syndrome. 
Introduction 
Congenital cardiac malformations are the most 
common life-threatening birth defects [1].  Most major 
malformations are detected at birth, but less severe 
defects can go undetected, leading to cardiac disease 
later in life [2].  In mice, the development of the heart 
begins with the formation of the cardiac tube, which 
soon undergoes dextral looping and other morpho-
genic events to form the heart chambers [3].  During 
this process, the ventricles and atria become partially 
separated by the formation of atrioventricular cu-
shions.  The valves and septa arise from these cu-
shions, through inductive influences from the under-
lying myocardium [4-6]. 
Transforming growth factor β (TGFβ) and bone 
morphogenic protein (BMP) ligands and/or their re-
ceptors are expressed by myocardium, endocardium, 
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cushion mesenchyme, epicardium, cardiac neural 
crest cells and second heart field cardiac progenitor 
cells [7-9]. Mice with gene targeted mutation in TGFβ 
or BMP pathways exhibit multiple cardiovascular 
developmental defects, including valvuloseptal septal 
defects [10-20].  These malformations are consistent 
with myocardial TGFβ2 and BMP2/4 acting on the 
overlying cushion to promote an epithelial to mesen-
chymal transition of a distinct group of endocardial 
cells [21,22].   
The TGFβs and BMPs are members of the TGFβ 
superfamily of proteins, which signal through a com-
plex consisting of type I and II receptors.  Signal 
transduction is mainly through the SMAD pathway 
[23], although other pathways such as PI3K-Akt and 
Ras-Raf have been implicated in some physiological 
events [24].  There are 8 SMADs, which can be 
sub-divided into three functional groups.  The recep-
tor-mediated SMADs (SMAD1, 2, 3, 5, 8) are directly 
phosphorylated by the TGFβ receptors, and then 
translocated to the nucleus, after binding to the single 
co-mediator SMAD, SMAD4 [24].  The inhibitory 
SMADs (SMAD6, 7) reduce signaling by preventing 
activation of the receptor mediated-SMADs [23]. 
SMAD6 appears to be specific for BMP signaling, 
whereas SMAD7 can reduce either BMP or TGFβ 
based signaling pathways [25-27]. 
The role of the single co-mediator SMAD, Smad4, 
in the myocardium is unclear due to variations in the 
timing and efficiency of previous myocardial-specific 
deletions of Smad4 [28-30].  Smad4 deficient embryos 
die shortly after implantation [31], but the broad ac-
tions of SMAD4 can be investigated through 
cell-specific deletions [32-35].   We report here that a 
broad myocardial conditional deletion of Smad4 pro-
duces a double-outlet right ventricle (DORV), as well 
as other cardiac malformations.  This suggests that 
myocardial-SMAD4 has a more extensive role in car-
diac morphogenesis than currently reported.  The 
novel alpha skeletal muscle actin Cre transgenic 
mouse (MuCre) used in this study produces early, 
rapid and robust cleavage of floxed genes, making it a 
valuable tool for the study of both cardiac and skeletal 
muscle formation. 
Materials and Methods 
Animals 
The University of Otago’s Animal Ethics Com-
mittee approved all experiments.  Mice were bred and 
maintained in M.I.C.E.™ cages and their food steri-
lized by gamma irradiation.  The room had a 14h 
white light / 10h dark-sodium light phase [35].  
Floxed-Smad4 (Smad4flox/flox) [36] and ROSA26LacZ [37] 
mice were bred at the University of Otago.  
Generation of MuCre mice  
The MuCre mice carried a transgene consisting of 
a human alpha skeletal muscle actin promoter [38] 
and the bacteriophage P1 Cre recombinase gene [39].  
The DNA fragments containing the α-skeletal muscle 
actin promoter and the Cre recombinase gene were 
isolated from the original clones, integrated into a 
new cloning vector using standard techniques.  The 
construct was verified by nucleotide sequencing.  The 
transcription unit was then isolated by cleavage of the 
clone with restriction endonucleases, preparative 
agarose gel electrophoresis and a DNA isolation kit 
(QIAGEN).  It was then injected into C57BL/6 zygotes 
(TASQ, University of Queensland, St Lucia, Australia) 
and the MuCre line was selected from 14 founders, as 
it had the highest level of Cre recombinase expression.  
Two different Cre transgenic lines (MuCreA and 
MuCreB) were generated and characterised. These 
lines were maintained by breeding transgenic mice 
with C57BL/6 mice. MuCre refers to the A line, unless 
otherwise stated.  The mice are available from the 
Riken Bioresource Centre (#RBRC01386, MuCre-A).   
The genotype of the mice was determined from 
ear biopsies, using polymerase chain reaction (PCR), 
as previously described [40].  The primers used were: 
Floxed Smad4, 5’-GGGCAGCGTAGCATATAAGA-3’ 
and 5’-TGACCCAAACGTCACCTTCA-3’; 
ROSA26LacZ, 5’-GTTGCAGTGCACGGCAGATACAC 
TTGCTGA-3’ and 5’-GCCACTGGTGTGGGCCATAA 
TTCAATTCGC-3’; MuCre, 5’-GTTGATGCCGGTGAA 
CGTGCAAA-3’ and 5’-ATCAGCTACACCAGAGA 
CGGAAA-3’. 
The tissue-specificity of Cre expression was 
examined by quantitative (q) PCR.  Total RNA was 
extracted from the brain, spinal cord, kidney, liver, 
gastrocnemius muscle and heart using TRIzol reagent, 
according to the manufacturer’s instructions (Invi-
trogen, Carlsbad, Ca, USA).  The total RNA fractions 
of each sample were DNase treated to remove possi-
ble contamination of genomic DNA and then reverse 
transcribed using SuperScript II Rnase H- reverse 
transcriptase (Invitrogen) and oligo d(T)15 as primer. 
Cre cDNA were amplified using primers CreER-F2 
(5'–GTT GAT GCC GGT GAA CGT GCA AA-3') and 
CreER-R1 (5'–ATC AGC TAC ACC AGA GAC GGA 
AA-3').  GAPDH cDNA were co-amplified using 
primers GAPDH-forward (5'–CTT CAT TGA CCT 
CAA CTA-3') and GAPDH-reverse (5'–TTC ACA 
CCC ATC ACA AAC-3') and used as internal control. 
Real-time PCR were performed using SYBR Green 1 
dye (Invitrogen). Measurements were realized and 
analyzed by using the ABI Prism 7700 sequence de-
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tection system (Applied Biosystems, Foster City, CA, 
USA).  
The characteristics of the MuCre mice were also 
verified by breeding them with LacZ/alkaline phos-
phatase (Z-AP) double reporter and ROSA26LacZ re-
porter mice [37, 41].  In the Z-AP mice, the action of 
Cre recombinase terminates the production of LacZ 
and induces alkaline phosphatase (AP) [41].  Suc-
cessful cleavage is thus indicated by both the loss of 
LacZ stain and the induction of AP expression. 
Embryos were produced at E11.5, E14.5 and 
E16.5 from time-mated pregnancies, with the date of 
the vaginal plug designated as E0.5.  A proportion of 
these were stained in situ for LacZ.  The dams were 
killed, the embryos removed and fixed in a solution 
containing 0.2% glutaraldehyde, 5mM EGTA, 2mM 
MgCl2 in phosphate-buffered saline (PBS) for 10 mi-
nutes at 4°C.  The embryos were washed three times 
in PBS containing 2mM MgCl2 and 1% NP40, and 
incubated in a solution containing 2.45mM X-Gal, 
2mM MgCl2, 20mM K3Fe(CN)6, 20mM K4Fe(CN)6 in 
PBS for 3 hours.  After washing three times in PBS, the 
embryos were fixed again overnight at 4°C, embed-
ded in Technovit 7100 resin and serially-sectioned at 
15µm. 
Tissues from embryos and adults were snap 
frozen in melting isopentane, and sectioned using a 
cryostat.  LacZ staining of the section was as pre-
viously described [42].  For alkaline phosphatase (AP) 
staining, the sections were fixed with 2% parafor-
maldehyde in 0.1M sodium phosphate buffer, pH 7.4, 
washed in AP buffer (100mM Tris-HCl pH 9.5, 
100mM NaCl and 5mM MgCl2) for 2 minutes and 
incubated in 318µg/ml nitroblue tetrazolium, 
108µg/ml 5-bromo-4-chloro-3-indolyl phosphate, 
para-toluidium salt and 102µg/ml levamisole in AP 
buffer for 10 minutes. 
The Cre recombinase-ERT contains a ta-
moxifen-sensitive estrogen receptor domain, which is 
designed to hold the Cre recombinase in the cyto-
plasm of the cell, unless tamoxifen is present [39]. This 
enables temporal control of the cleavage of target se-
quences, but this strategy is only effective in some 
mouse lines [43].  The MuCre mice rapidly cleaved 
target sequences in the absence of tamoxifen, indicat-
ing that the Cre recombinase enters the nucleus in-
dependent of tamoxifen.  The data presented here are 
therefore from mice that did not receive tamoxifen. 
Assessment of cardiac malformations 
The embryos produced by crossing Mu-
Cre/Smad4flox/+ and Smad4flox/flox mice were fixed in 4% 
paraformaldehyde in 0.1M phosphate buffer, pH7.4.  
The hearts from five MuCre/Smad4flox/flox and six con-
trol mice were embedded in wax, serially sectioned at 
5µm and stained with hematoxylin and eosin for the 
histological and morphometric examination. 
Results 
MuCre mice have cardiac and skeletal muscle expression of 
Cre recombinase 
Muscle-specific Cre recombinase transgenic 
mouse lines (MuCre) were generated using an α ske-
letal muscle actin promoter.  The endogenous 
α-skeletal muscle actin promoter is skeletal-muscle 
specific, but when used in transgenic mice it drives 
expression in the heart, in a minority of mouse lines 
[38].  Consistent with this, the hearts of adult MuCre 
mice had levels of Cre recombinase mRNA that varied 
from 0.1% (line B) to 40% (line A, MuCrA, hereafter 
referred to as MuCre) of the level in skeletal muscle.  
Cre recombinase mRNA was not detected in the 
brain, spinal cord, liver or kidneys of the MuCre mice.  
The MuCre mice alone did not exhibit a phenotype.  
The cells expressing the Cre recombinase were 
examined by crossing the MuCre mice with a 
ROSA26LacZ and/or the Z-AP reporter mice, with the 
observed pattern of stain being consistent with the 
mRNA data.  In whole mount E11.5 Mu-
Cre/ROSA26LacZ embryos, the LacZ reporter staining 
was detected in the developing heart and skeletal 
muscles (Fig. 1A).  Sectioning of the heart revealed 
strong staining in the myocardium of atria, ventricles 
and outflow tract (outflow tract) and atrioventricular 
(AV) canal myocardium, but not in the endocardial 
cushions (Fig. 1B). Skeletal myotubes were also 
stained (red arrows in Fig. 1B). 
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Fig. 1 MuCre-driven expression of ROSA26LacZ reporter gene in developing skeletal and cardiac muscle 
cells. A: Whole mount LacZ staining in E11.5 MuCre/ROSA26LacZ and a littermate non-transgenic control fetuses.  The white 
arrow points to LacZ stain in the heart. B: The MuCre/ROSA26LacZ fetuses were stained for LacZ, embedded in Technovit 
resin and serially sectioned.  The LacZ stain was present in cardiac myocytes (black arrow) and skeletal muscle myotubes 
(red arrowheads) of the developing limb (L).  EC, endocardial cushion; LA, left atrium; LV, left ventricle; RA, right atrium; RV, 
right ventricle.  The scale bar represents 500 µm. 
 
Fig. 2 MuCre-driven expression of the Z-AP reporter genes in skeletal muscle myotubes and fibers.  With the 
Z-AP reporter, Cre activity is detected by the expression of alkaline phosphatase (AP) and the cessation of LacZ expression. 
A, D: Sections of skeletal muscle from an adult non-transgenic Z-AP reporter mouse.  All muscle fibres were LacZ-positive 
and AP-negative (A and D respectively).  The expression of AP was restricted to resident macrophages (arrows in D). B, C, 
E, F, G:  Sections of skeletal muscle from adult (B, E), neonatal (C, F) or E16.5 (G) MuCre/Z-AP mice.  Activation of Cre was 
limited to the myogenic cells, which were AP-positive (E, F and G) and LacZ-negative (B and C).  The non-myogenic cells in 
the muscle lack Cre expression.  For example, the arrow in (B) points to an intramuscular nerve, whereas the arrowheads 
in (C, F) point to an intramuscular tendon, which had minimal expression of reporter genes.  The AP-positive myotubes in 
(G) are indicated by an arrowhead, whereas the AP-negative mononucleated cells are indicated by arrows. It is also 
noteworthy that the AP staining of muscle fibers in (E) is specific because AP staining is absent in the negative control (D). 
The scale bar = 50µm (A-F) and 30 µm (G). 
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The tissue-specific expression of the MuCre mice 
was then examined using cryostat sections of Mu-
Cre/Z-AP mice, with Cre recombinase expression be-
ing detected by the induction of alkaline phosphatase 
(AP) and the cessation of LacZ expression.  In control 
non-transgenic Z-AP mice all cells were LacZ positive 
and AP negative (compare Fig 2A with 2D).  By con-
trast, the skeletal muscles of the MuCre/Z-AP mice, the 
muscle fibers were LacZ negative (Fig. 2B) and AP 
positive (Fig. 2E), indicating that all muscle fibers had 
produced high levels of Cre recombinase.  The inters-
titial cells of the muscles, including neural 
crest-derived Schwann cells (arrow in Fig. 2B) were 
LacZ positive.  The expression of AP was limited to a 
small population of resident macrophages that natu-
rally produce AP (arrows in Fig. 2D).  The complete 
removal of LacZ and the induction of AP were also 
observed in all myotubes (immature muscle fibers) of 
E14.5, E16.5 and newborn MuCre/Z-AP mice (compare 
Fig. 2C with 2F).  The myoblasts and other mononuc-
leated cells were negative for AP (arrows in Fig. 2G).  
This indicates that the cleavage of target DNA in the 
myotubes was very rapid, as many of these immature 
muscle fibers were only a few hours old.  All cardiac 
myocytes of the adult MuCre/Z-AP mice were AP 
negative (Fig. 3D) and LacZ positive (Fig. 3B).  By 
contrast, no cleavage of the reporter construct was 
observed in control hearts, with the myocytes being 
LacZ negative (Fig. 3A).  No cleavage of the reporter 
gene was observed in other tissues, including the 
brain, spinal cord, liver and intestines. In summary, 
the MuCre mouse line specifically express Cre recom-
binase in cardiac and skeletal muscles.  The level of 
expression of the Cre recombinase in both these mus-
cle types is high leading to extremely rapid and robust 
cleavage of target sequences. 
Muscle-specific deletion of Smad4 leads to mid-gestational 
lethality 
MuCre/Smad4+/flox mice were crossed with 
Smad4flox/flox mice to produce MuCre/Smad4flox/flox 
(hereafter referred to as myocardial Smad4 conditional 
knockout) mice. Sixty 10-day-old pups were produced 
from 14 litters. The data indicated that myocardial 
Smad4 conditional knockout died in utero (Table 1). 
The fetuses from 19 time-mated litters were therefore 
collected.  Myocardial Smad4 conditional knockout 
fetuses were present at the Mendelian ratio (32/125, 
Table 1), but most of the conditional knockout fetuses 
older than 13-14 days of gestation were dead in utero 
(Table 1). The death of the myocardial Smad4 condi-
tional knockout fetuses was independent of whether 
the MuCre transgene was carried by the dam or by the 
stud. 
 
 
Table 1. Significant mid-gestational embryonic lethality in 
myocardial Smad4 conditional knockout mice. 
Genotypes E12.5-13.5 E14.5 E18.5 P10 
Smad4flox/+  
(control) 
6 (14%) 12 (35%) 12 (24%) 18 (30%) 
Smad4flox/flox  
(control) 
13 (30%) 8 (24%) 14 (28%) 16 (27%) 
MuCre/Smad4flox/+ 10 (23%) 6 (18%) 12 (24%) 26 (43%) 
MuCre/Smad4flox/flox 14 (33%) 2 [6] (6, 
18%) 
2 [8] (4, 
16%) 
0 (0%) 
Number of fetus-
es/mice 
43 34 50 60 
Number of litter 5 5 6 10 
MuCre/Smad4flox/+ and non-transgenic Smad4flox/flox mice were 
mated and their offspring genotyped.  The numbers of dead fetuses 
are indicated in square brackets. Note the significant decrease in the 
number of live myocardial Smad4 conditional knockout embryos 
between E13.5 and E14.5 indicates a mid-gestational lethality. 
 
 
Loss of Smad4 in myocardium causes defects in cardiac 
morphogenesis 
Histological examination by hematoxylin and 
eosin (H&E) staining was done on serial sections of 
E11.5-13.5 fetuses of myocardial Smad4 conditional 
knockout (n = 7) and the littermate MuCre 
non-transgenic Smad4flox/flox control embryos (n = 5) to 
determine why the fetuses with myocardial Smad4 
deletion die.  At E11.5, the transgene was strongly 
expressed (Fig. 1), but all of the fetuses were still via-
ble (Table 1).  The control fetuses had a normal cardiac 
outflow tract and AV septation and alignment, com-
pact ventricular myocardium, and the endocardial 
cushions (Fig. 4A,C,E,G). By contrast, myocardial 
Smad4 conditional knockout fetuses exhibited cardiac 
defects, including double-outlet right ventricle 
(DORV) (Fig. 4D,H), ventricular septal defect (VSD) 
(Fig. 4D,H), decreased density of trabeculae in the 
ventricles and thinning of the compact layer of the 
ventricular myocardium (Fig. 4B,D,H,F). DORV was 
seen with the aortic orifice being in a side-by-side 
position to the pulmonary orifice (Fig. 4B). In control 
embryos, tissue between aortic valve and right ven-
tricular outflow tract became myocardial structure 
(Fig. 4C). By contrast, only a small fibrous ridge se-
parated the aortic valve from the right ventricular 
outflow tract in myocardial Smad4 conditional 
knockout fetuses (Fig. 4D). This can be attributed to 
the fact that the outlet cushions are proximally not 
fused in the conditional knockout embryos (Fig. 4D). 
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The cardiac phenotype was the same in all embryos 
examined, indicating that the penetrance of the ge-
netic modification is very high. 
In the control E13.5 embryos, the fusion of me-
senchyme at the base of the atrial septum and AV 
cushions nearly completed the inlet septation. How-
ever, in the myocardial Smad4 conditional knockout 
embryos, there was a large perimembranous inlet 
ventricular septal defect (VSD) due to absence of me-
senchyme in the region where outflow tract and the 
AV cushions should have met (Fig. 4H). The VSD was 
more closely related to the aortic orifice in the condi-
tional knockout embryo (Fig. 4D). It is also notewor-
thy that the bifurcated outflow tract is in the right 
ventricle and not over the ventricular septum (Fig. 
4D).  The size and the cellularity of endocardial cu-
shions were normal, but their appearance was slightly 
abnormal (Fig. 4H), which we attributed to the im-
paired cardiac alignment process in the conditional 
mutants. 
 
 
 
 
Fig. 3 MuCre-driven expression of the Z-AP reporter genes in adult cardiac myocytes.  With the Z-AP re-
porter, Cre activity is detected by the expression of alkaline phosphatase (AP) and the cessation of LacZ expression. A,C: 
The hearts from control non-transgenic Z-AP reporter mice were LacZ negative and had high levels of AP.  B,D: All 
myocytes in the hearts of MuCre/Z-AP mice were LacZ positive (B) and only had low endogenous AP expression (D).   The 
black (A, B) and the white arrows in (C,D) point to myocytes. V, ventricle. The bar represents 500 µm. 
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Fig. 4 SMAD4 is essential for cardiac morphogenesis.  A-F: Light micrographs of serial sections of E13.5 
non-transgenic control (A, C, G, E) or MuCre/Smad4flox/flox (B, D, H, F) fetuses stained with haematoxylin and eosin.  Asterisk 
(*) in B shows an abnormal side-by-side alignment of aorta (ao) and pulmonary trunk (pt) leading to the DORV.  (D) Asterisk 
(*) in D indicates missing right ventricular outflow tract septum and a fully developed double-outlet right ventricle (DORV) 
in the myocardial Smad4 conditional knockout embryo. A clear ventricular septal defect is seen in D (double asterisks) H 
(asterisk) in the myocardial Smad4 conditional knockout embryo. Note that the DORV is positioned in the right ventricle 
and not over the ventricular septum (double asterisk in D). Impaired myocardial trabeculation and myocardial hypoplasia in 
the interventricular septum (arrow in D and H), and thinning of the compact layer of the ventricular myocardial walls (D, H, 
F) (arrowhead in D & H) is found in the myocardial Smad4 conditional knockout. E-F are 100% zoomed or enlarged images 
of the boxed regions in G & H, respectively. pv, pulmonary valves; rv, right ventricle; lv, left ventricle; ra, right atrium; la, left 
atrium; ivs, interventricular septum; mv, mitral valves; tv, tricuspid valves.  The scale bars = 200 µm (A-H). 
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Discussion 
This study provides clear evidence that mus-
cle-specific deletion of Smad4 leads to defective 
alignment but not septation of the aortic and pulmo-
nary orifices, resulting in DORV.  Interestingly, car-
diac phenotypes of myocardial Smad4 conditional 
knockout mice shares many similarities to the cardiac 
phenotypes observed in Tgfb2-/-, and TGFβ receptors 
and Bmp2, Bmp4 and BMP receptors conditional 
knockout mice [10,12-20,45]. Both TGFβ and BMP 
ligands play important roles in cardiac morphogene-
sis by properly recruiting second-heart field progeni-
tors to the outflow tract and to the ventricular myo-
cardium to the developing heart [45,46]. The data 
suggest a unique requirement of myocar-
dium-produced SMAD4 in the outflow tract align-
ment since endothelial or cardiac neural crest 
cell-specific deletion of Smad4 leads to defects in cu-
shion formation or outflow tract septation but not in 
misalignment of the outflow tract [47,48].  
The cardiac phenotype of the Mu-
Cre/Smad4flox/flox mice is more extensive than pre-
vious studies of myocyte-specific deletion of Smad4, 
which have used different promoters to drive the Cre 
recombinase [28-30].  The Smad4flox/flox mice used in 
these studies are from a common lineage [36], sug-
gesting that the difference in the phenotype relates to 
the characteristics of the promoters.  Alternatively, the 
phenotypes of mice with TGFβs mutations are influ-
enced by their genetic background [49-51] and by en-
vironmental factors [52], and SMAD4 biology could 
thus be subject to similar regulation. 
The development of the heart can proceed nor-
mally with attenuated growth factor signaling, as 
evidenced by the normality of MuCre/Smad4flox/+ mice 
(this study) and mice with single gene haploinsuffi-
ciency for Tgfb2, Bmp2 or Bmp4 [10,12,13,53].  The 
success of conditional genetic manipulation is thus 
dependent on early and rapid removal of both alleles 
of the target gene.  Similarly, it may be important for a 
high percentage of cells to be affected, as a minority of 
normal cells may be sufficient to drive some mor-
phogenetic events.  The MuCre mice effectively 
achieve these criteria, as evidenced by the speed and 
completion of removal of floxed genes in the 
ROSA26LacZ and Z-AP reporter mice, and by the se-
verity of the phenotype of MuCre/Smad4flox/flox mice. 
The cardiac malformations in Mu-
Cre/Smad4flox/flox mice are concordant with other re-
cent studies of myocyte-specific deletion of Smad4, 
which have used αSMACre and cTntCre mice [29,30], 
except for DORV, which is unique to the Mu-
Cre/Smad4flox/flox mice.  The inductive events that un-
derlie DORV precede those that underlie the other 
malformations, and presence of DORV in the Mu-
Cre/Smad4flox/flox may be because the MuCre mice 
drive early and possibly more robust removal of 
floxed genes as compared to the αSMACre driver 
mouse lines. Although cTnt-Cre mice were effective in 
robustly deleting Smad4 in early myocardial progeni-
tors at E7.5, it was not possible to determine DORV in 
cTnt-Cre/Smad4flox/flox mice due to their death before 
E12.5. Many studies suggested that an interaction 
between cardiac neural crest cells and second-heart 
field-derived myocardium play an important role in 
outflow tract septation and alignment [45]. Since the 
current study shows that outflow tract is correctly 
septated but improperly aligned, it is possible that a 
defective interaction between cardiac neural crest and 
second-heart field-derived outflow tract myocardium 
is involved in the formation of DORV in myocardial 
Smad4 conditional knockout embryos.  
Alpha-myosin heavy chain 
αMHCCre/Smad4flox/flox mice exhibit normal heart 
development, which is in marked contrast to the Mu-
Cre, αSMACre, cTntCre equivalents.  αMHCCre mice 
are commonly used to study cardiac biology, and 
have proven utility for the study of adult function 
[41,54].  Their use for the study of cardiac develop-
ment has yielded conflicting results and the expres-
sion of Cre in αMHCCre mice may be insufficiently 
strong or not early to affect all aspects of myocardial 
development [28,30,55].  While it is difficult to draw 
any parallel between MuCre and αMHCCre expres-
sion, it is clear that MuCre mice effectively delete 
genes in myocardium during early cardiac develop-
ment and in the adulthood.   
The MuCre mice were initially developed to 
study skeletal muscle formation, and they provide 
rapid and complete removal of floxed genes from 
myotubes.  The MuCre mice may therefore be useful 
for the study of skeletal myogenesis, provided the 
target gene is not expressed in the heart.  The dual 
skeletal and cardiac effects of MuCre mice are less 
problematical for the study of the heart, as embryos 
develop to term in the complete absence of skeletal 
muscle [44].    
In summary, we report the generation of a new 
line of α-skeletal-actin Cre-recombinase transgenic 
mice, which should facilitate the study of cardiac and 
skeletal myogenesis.  The value of these mice is evi-
denced by their use to provide new insight into the 
role of Smad4 in outflow tract morphogenesis 
processes during heart development.  
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